Paediatricians across India raise alarm over increasing child medication overdoses caused by confusing drug formulations.

Despite increased labeling of drugs with pediatric information, most medicines remain available only as pills meant for ...

Following the successful closure of its initial public offering (IPO), investor focus has now shifted to the allotment.

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Southwest Research Institute (SwRI) and Trinity University will improve a prodrug, a compound activated in the body, to ...

The rate of severe infections decreased from 2 infections to 0.2 infections per PYO after treatment with etuvetidigene autotemcel.

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

Pfizer PFE announced that it is in-licensing exclusive global rights to develop, manufacture and commercialize YP05002, an oral small molecule GLP-1 receptor agonist (GLP-1 RA) from YaoPharma, a ...

GLP, specifically GLP-1, and GIP act through complementary biological pathways that together can potentially improve glucose metabolism, energy balance, and weight regulation. By targeting both ...

PCCA Adds to Its Family of USP Verified Excipient Compounding Bases ...

Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...